|
Ze-Li
Gao, Fo-Hu Jiang, Department of Gastroenterology, Baogang Hospital,
Shanghai Second Medical University, Shanghai 201900, China
Xiao-Hong Gu, Feng-Tao Cheng, Department of Gastroenterology, Yangpu
District Hospital, Shanghai 200090, China
Correspondence to: Dr. Ze-Li Gao, Department of
Gastroenterology, Baogang Hospital, Shanghai Second Medical
University, Shanghai 201900, China. gzeli@sina.com
Telephone: +86-21-56691101-6260
Received: 2002-12-28
Accepted: 2003-02-18
Abstract
AIM: To appraise the effect of sea buckthorn (Hippophae
rhamnoides) on cirrhotic patients.
METHODS:
Fifty cirrhotic patients of Child-Pugh grade A and B were randomly
divided into two groups: Group A as the treated group (n=30),
taking orally the sea buckthorn extract, 15 g 3 times a day for 6
months. Group B as the control group (n=18), taking vitamin B
complex one tablet, 3 times a day for 6 months. The following tests
were performed before and after the treatment in both groups to
determine LN, HA, collagens types III and IV, cytokines IL-6 and TNFa,
liver serum albumin, total bile acid, ALT, AST and prothrombin time.
RESULTS:
The serum levels of TNFa,
IL-6, laminin and type IV collagen in group A were significantly
higher than those in the control group. After a course of sea
buckthorn treatment, the serum levels of LN, HA, collagen types III
and IV, total bile acid (TBA) decreased significantly as compared
with those before and after treatment in the control group. The sea
buckthorn notably shortened the duration for normalization of
aminotransferases.
CONCLUSION: Sea buckthorn may be a hopeful drug for prevention and
treatment of liver fibrosis.
Gao
ZL, Gu XH, Cheng FT, Jiang FH. Effect of Sea buckthorn on liver
fibrosis: A clinical study. World J Gastroenterol
2003; 9(7): 1615-1617
http://www.wjgnet.com/1007-9327/9/1615.asp
INTRODUCTION
Liver cirrhosis is a common chronic hepatic injury caused by chronic
hepatitis B, ethanol consumption and metabolic disorders, etc. The
patients often die of hepatic failure due to portal hypertension,
bleeding of esophageal and gastric varices. Recent studies have
shown that fat storing cells now called hepatic stellate cells (HSCs)
are the main collagen producing cells in fibrotic liver. Under the
influence of inflammatory cytokines, vitamin A- rich cells are
activated, proliferating and transforming into myofibroblasts,
producing extracellular matrix(ECM)[1,2]. Retinoic acid
droplets and retinoic acid receptors (RAR) diminish. Recent studies
have also shown that when retinyl esters and RAR contents are
restored in HSC, HSCs would remain in the inactivated state. Hence
HSCs are regarded as the therapeutic targets for prevention and
treatment of hepatic fibrosis[3]. In this study, sea
buckthorn (Hippophae rhamnoides,) was used in cirrhotic patients to
determine its effect on the changes of fibrotic parameters,
improvement of liver function and whether it could be used as a
therapeutic antifibrotic agent.
MATERIALS
AND METHODS
Subjects
Fifty patients aged 20-70 years were enrolled in this study
with at least an elevation of two items of the following parameters,
e,g, serum collagen types III and IV, laminin (LN), hyaluronic acid
(HA). These patients were divided into treated group (group A, n=30,
25 hepatitis B cirrhosis and 5 alcoholic) and
control group (group B n=20, 17 hepatitis B cirrhosis
and 3 alcoholic). These two groups had similar demographic
characteristics. All these patients had not taken any antifibrotic
drug or immunomodulator or antiviral herbs in the past 6 months.
Group A received sea buckthorn extract in fine granules
(manufactured by Sichuan Pharmaceutical Co.LTD, China), 15 g, three
times a day for 6 months. Group B received vitamin-B complex, 2
tablets once, 3 times a day for 6 months.
Measurement
of cytokines, parameters of liver fibrosis and liver function tests
Cytokine: IL6 and TNFa
were measured by enzyme-linked immunosorbent assay (ELISA). LN, HA,
collagen types III and IV were measured by radioimmunoassay (RIA).
Serum albumin (Alb), total bilirubin, aspartate aminotransferase(AST),
alanine aminotransferase (ALT), alkaline phosphatase(ALP),
conjugates, total bile acid (TBA), prothrombin time (PT) were
measured by a biochemical autoanalyzer.
Statistical analysis
All data were analyzed with SAS software. The results were
expressed as mean ± standard deviation, the rate of normalization
of AST, ALT was analyzed by Chi-square test. LN, HA, Alb, TBA, PT,
collagen types III and IV were analyzed by signed rank test (both
pre-and posttreatment in the same group) and Wilcoxon rank test
(between the two groups, pre-and post treatment
for comparison). P value <0.05 was considered
statistically significant.
RESULTS
Determination of TNFa,
IL-6, LN, HA
The levels of TNFa,
IL-6, LN, collagen type IV in the 50 cirrhotic patients were
significantly higher than those in the controls (P<0.05).
There were positive correlations between TNFa,
IL-6 and LN, collagen type IV (Table 1).
Table 1 Measurements
of TNFa,
IL-6, LN, type IV collagen (
)
| Group |
n |
TNFa(ng/L) |
IL-6(ng/L) |
LN(mg/L) |
Type
IV(ng/L) |
| A |
30 |
19.6±3.2 |
15.1±2.8 |
374.1±31.2 |
250.9±22.6 |
| B |
20 |
6.7±1.2 |
3.8±1.1 |
99.4±6.8 |
51.8±4.6 |
| t
value |
|
2.419 |
2.961 |
2.618 |
2.997 |
| P
value |
|
<0.05 |
<0.05 |
<0.05 |
<0.05 |
Table 2
Normalization rates of AST,ALT (
)
|
AST
(IU/L) |
Normalization
rate(%) |
ALT
(IU/L) |
Normalization
rate(%) |
| Group |
Before
treatment |
After
treatment |
Before
treatment |
After
treatment |
| A |
59.87±26.70 |
49.03±18.99 |
24/30(80)a |
50.57±32.47 |
44.12±26.05 |
24/30(80)a |
| B |
154.75±20.21 |
47.85±23.53 |
10/18(56) |
41.65±23.54 |
39.15±16.68 |
10/18(56) |
aP<0.05
vs controls.
Table 3
Parameters of liver fibrosis ( )
| Parameters |
Group |
Before
treatment |
After
treatment |
Comparison
of two groups |
| Stat
Z |
P
value |
| III
(ng/l) |
A |
428.43±196.02 |
149.43±75.91 |
|
|
| |
B |
423.56±251.41 |
169.80±138.94 |
0.0403 |
0.0394 |
| IV (ng/l) |
A |
123.98±81.22 |
70.00±34.45 |
|
|
| |
B |
178.32±89.45 |
139.85±98.15 |
0.0393 |
0.0384 |
| LN
(mg/l) |
A |
210.91±165.12 |
136.51±105.56 |
|
|
| |
B |
211.56±188.91 |
156.00±100.00 |
0.0073 |
0.0070 |
| HA
(mg/l) |
A |
516.74±338.75 |
240.56±169.78 |
|
|
| |
B |
494.74±272.26 |
387.16±196.28 |
0.0148 |
0.0144 |
Wilcoxon rank test.
Table 4
Changes of TBA, PT, Alb (
)
| Parameters |
Group |
Before
treatment |
After
treatment |
Before
treatment |
Before/after
treatment |
Comparison
of two groups before/after treatment |
| Stat( Z ) |
P
value |
Stat( t
) |
P
value |
Stat (S) |
P value |
| TBA
(ng/l) |
A |
38.70±27.50 |
22.83±12.28 |
|
|
189.32 |
0.0001 |
|
|
|
B |
40.50±34.02 |
38.55±22.60 |
0.751 |
0.743 |
35.55 |
0.1922 |
545.0 |
0.0003 |
| PT
(sec) |
A |
14.57±0.97 |
13.50±0.73 |
|
|
7.443 |
0.0001 |
|
|
|
B |
15.15±0.93 |
14.40±0.74 |
4.35 |
0.048 |
5.252 |
0.0001 |
2.21 |
0.1415 |
| Alb
(g/l) |
A |
34.07±9.35 |
35.13±7.13 |
|
|
1.205 |
0.238 |
|
|
|
B |
27.45±7.41 |
27.40±6.25 |
7.02 |
0.010 |
0.053 |
0.958 |
0.48 |
0.4887 |
Signed rank test and Wilcoxon rank
test.
ECM
parameters and liver function tests
Remarkable changes were found in AST and ALT after sea
buckthorn treatment. The rate of normalization was 80 % in the
treated group and 56 % in the control group (P<0.05). No
difference was found in serum albumin and prothrombin time. In group
A, serum LN, HA, total bile acid (TBA), collagen types III and IV
were decreased after treatment as compared with group B. There was a
significant difference between the two groups (P<0.05).
(Tables 2-4).
DISCUSSION
Sea buckthorn is a plant growing in severely cold region of
South-west China, its fruit juice has been taken as a tonic by the
local Mongolians and Tibetans. It contains a great deal of vitamins,
amino acids and trace elements, which are beneficial to human health[4].
Recent studies have shown that sea buckthorn contains lots of
vitamin A precursors including b
carotene
and unsaturated fatty acids. Zhao et al[5]
reported that sea buckthorn could protect the liver from damage by
CCl4. A combination of an antiviral drug and sea
buckthorn in treating patients with chronic hepatitis B could
shorten the duration for the normalization of serum ALT. The rate of
turning negative of HBeAg and HBsAg was 52.16 % and 16.67 %,
respectively[6].
In the normal liver, HSCs are mainly involved in the storage
of vitamin A. In addition, they synthesize extracellular matrix
components, matrix degrading metalloproteinases, cytokines, and
growth factors[7,8]. Following acute or chronic liver
injury, HSCs are activated and undergo a process of
transdifferentiation, leading to a myofibroblastic phenotype. The
activated HSCs are characterized by a loss of vitamin A droplets,
increase of proliferation, release of proinflammatory, profibrogenic,
and promitogenic cytokines and migration to the sites of injury with
increased production of extracellular matrix components and
alterations in matrix protease activity and provision for the
fundamental needs of tissue repair[9]. In acute or
self-limited liver damage, these changes are transient, whereas in
case of persistent injury, they lead to chronic inflammation with an
accumulation of extracellular matrix, resulting in liver fibrosis
and ultimately cirrhosis. Several growth factors and cytokines are
involved in HSCs activation and proliferation, of which transforming
growth factor b
(TGFb),
platelet derived growth factor (PDGF), TNFa
and IL-6 are probably the most important ones[10].
TNFa
is not only an anticancer factor, but also participates in the
process of immunologic reaction and inflammation. The synthesis of
collagen and some extracellular matrices were
elevated 3 fold and 2.6 fold, respectively when rat HSCs were
incubated with TNFa
(5.0 nmol/l) for 24 hours[11]. IL-6 is a cytokine which
has many biologic functions, such as promoting cell proliferation
and differentiation, regulating immune function. Wang et al[12,13]
reported IL-6 increased in the peripheral blood of an early animal
model of liver fibrosis, and the peripheral blood level of IL-6 in
cirrhotic patients was remarkably higher than that in those without[14].
HSCs
represent 5-8 % of all human liver cells. They have long cytoplasmic
processes which run parallel to the sinusoidal endothelial wall. The
second order branches sprout out from the processes, and embrace the
sinusoids. Some HSCs are in close contact with nerve endings, some
of which contain neuropeptides such as substance P, neuropeptide Y,
somatostatin, and calcitonin gene-related peptide[15,16].
Our
previous study showed[17] that retinoic acid receptor(RAR)
and cAMP of primarily cultured HSCs were
reduced, as compared with those in freshly isolated HSCs. The
contents of RAR and cAMP of cultured HSCs were increased after
treated with all-transretinoic acid (10-5 Mol/L).
Based
on the recent articles and our results, we may deduce that the
resting HSCs are activated by TNFa
and IL-6 released by Kupffer cells during the process of acute or
chronic inflammation, then TNFa
and IL-6 in turn stimulate Kupffer cells to release TGFb
and PDGF. Eventually, HSCs proliferation and synthesis of ECM, along
with the loss of vitamin A droplets, will transform themselves into myofibroblast producing
liver fibrosis[18,1
9].
The
present study showed that sea buckthorn could reduce the serum
levels of laminin, hyaluronic acid, TBA, collagen types III and IV
in patients with liver cirrhosis, indicating that it may restrain
the synthesis of collagen and other components of ECM. We are
attempting to restore vitamin A and RAR contents of HSCs, so as to
keep HSCs in a quiescent status and to prevent progression of liver
fibrosis. Sea buckthorn may be a hopeful drug for prevention and
treatment of liver fibrosis, but further well controlled clinical
trials are required.
REFERENCES
1
Norifumi K, Shuichi S, Masayasu I, Tetsuo K. Effect of
antioxidants, resveratrol, quercetin, and N-Acetylcysteine on
the function of cultured rat hepatic
stellate cells and kupffer cells. Hepatology 1998; 27: 1265-1274
2
Giuliano R, Thomas A. Cytokines in the liver. Eur J
Gastroenterol Hepatol 2001; 13: 777-784
3
Reynaert H, Thompson MG, Thomas T, Geerts A. Hepatic stellate
cells: role in microcirculation and pathophysiology
of portal hypertension. Gut 2002; 50:
571-581
4
Oomah BD, Sery C, Godfrey DV, Beveridge TH. Rheology of sea
buckthorn (Hippophae rhamnoides L) juice. J Agric
Chem 1999; 47: 3546-3550
5
Zao TD, Cheng ZX, Liu XY, Shao JY, Ren LJ, Zhang L, Chen WC.
Protective effect of the sea buckthorn oil for liver
injury induced by CCl4. Zhongcaoyao
1987; 18: 22-24
6
Huang DL, Chang XZ, Gui HN, Tian YD, Chen LX, Li ZP, Xing L. Analysis of 156
cases of chronic hepatitis treated
with
sea buckthorn. Zhongxiyi Jiehe Zazhi
1991; 11: 697-6980
7
Greerts A. History, heterogeneity, developmental biology and
functions of quiescent hepatic stellate cells. Semin Liver
Dis 2001; 21: 311-315
8
Schumann J, Tiegs G. Pathophysiological mechanisms of TNF
during intoxication with natural or man-made
toxins. Toxicology 1999; 138: 103-126
9
Lissoos TW, Davis BH. Pathogenesis of hepatic fibrosis and
the role of cytokines. J Clin Gastroenterol 1992; 15: 63-67
10 Friedman SL. Molecular
regulation of hepatic fibrosis, an integrated cellular response to
tissue injury. J Biol Chem
2000; 275:2247-2250
11
Knittel T, Muller L, Saile B, Ramadori G. Effect of tumor
necrosis factor -alpha on proliferation, activation and
protein synthesis of rat hepatic
stellate cells. J Hepatol 1997; 27:1067-1080
12
Weiner FR, Giambrone MA, Czaja MJ, Shah A, Annoni G,
Takahashi S, Eghbali M, Zern MA. Ito-cell gene expression
and collagen regulation. Hepatology
1990; 11: 111-117
13 Wang Q, Xia HS, Jiang
HY, Ma XX, Zhu F, Zuo LQ. The Immunologic regulation of liver in the
process of rat liver
fibrosis. Zhonghua Yixue Zazhi 1995;
75:594-598
14 Tili H, Lissoos TW.
Pathogenesis of hepatic fibrosis and the role of the cytokine.
Gastroenterology 1992; 103: 264-271
15
Burt AD, Le Bail B, Balabaud C, Bioulac-Sage P. Morphologic
investigation of sinusoidal cells. Semin Liver Dis
1993; 13: 21-38
16
Stoyanova II, Gulubova MV. Immunocytochemical study on the
liver innervation in patients with cirrhosis. Acta
Histochem 2000;102: 391-402
17 Gao ZL, Li DG, Lu
HM.The effect of retinoic acid receptor and cAMP of HSC cell.
Weichangbingxue He Ganbingxue
Zazhi 1995; 4: 20-22
18 Rebecca G, Wells.
Fibrogenesis V. TGF-? signaling pathways. Am J Physiol Gastrointest
Liver Physiol
2000; 279: G845-G850
19
Gangopadhyay A, Bajenova O, Kelly TM, Thomas
P.Carcinoembryonic antigen induces cytokine expression in
Kuppfer cells:implications for
hepatic metastasis from colorectal cancer. Cancer Res 1996; 56:
4805-4810
Edited
by Wu
XN and Wang XL
| |